The Comparison of RhoC and PI3K Gene Expression on the Breast Cancer Tissue and Benign Tumour Tissue

• Published in: Open access Macedonian journal of medical sciences Vol. 7; no. 12; pp. 1911 - 1916
• Main Authors: Arisanty, Dessy, Harahap, Wirsma Arif, Khambri, Daan, Rustam, Rony, Aliska, Gestina, Achyar, Affifatul, Menra, Juane Plantika
• Format: Journal Article
• Language: English
• Published: Macedonia Republic of Macedonia 30.06.2019
• Subjects: Basic Science; PI3K gene; Real-time PCR (qPCR); RhoC gene; Vector; Cloning
• DOI: 10.3889/oamjms.2019.543
• ISSN: 1857-9655

The expression of a gene is a process that conveys information of genes to synthesise gene product is functional. Alterations of the molecular biology in breast cancer are very complex because of many factors play a role in the tumorigenesis. is a prometastases gene. The gene is crucial in the regulation of multiple cellular functions, including cell growth, proliferation, metabolism and angiogenesis. This study aims to compare of and gene expression on the breast cancer tissue and benign tumour tissue. Expression of the and genes was carried out with qPCR. The absolute quantification method was using breast cancer tissue. As a comparison, benign tumours (FATs) tissue was carried out. The standard curves were obtained from cloning target genes, which were inserted into the gGEMT-easy vector from . The gene expression data was carried out by t-test to see the mean difference between the expression of breast cancer tissue and benign tumours (FATs) with a value of p ≤ 0.005 in and gene expression. And the relationship between expressions was done by Pearson correlation test. The results showed that it was found that gene expression on breast cancer tissue was higher than the number in a benign tumour (fibroadenoma mammae) as an endogenous control. And also, the expression of is much lower on breast cancer tissue compared with a benign tumour. This study concluded that expression of affects the expression of so that the thing this is what causes the proliferation and began to provide support aggressive cancer cells in the breast.